These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
62 related articles for article (PubMed ID: 7758989)
1. Effect of alpha IFN on unaggressive immunoproliferative disorders. Frigeri F; De Renzo A; Marcenò R; Ruggeri P; Musto P; Andriani A; Citarrella P; Caronia F; Rotoli B Haematologica; 1995; 80(1):35-9. PubMed ID: 7758989 [TBL] [Abstract][Full Text] [Related]
2. Adherence and mental side effects during hepatitis C treatment with interferon alfa and ribavirin in psychiatric risk groups. Schaefer M; Schmidt F; Folwaczny C; Lorenz R; Martin G; Schindlbeck N; Heldwein W; Soyka M; Grunze H; Koenig A; Loeschke K Hepatology; 2003 Feb; 37(2):443-51. PubMed ID: 12540795 [TBL] [Abstract][Full Text] [Related]
3. [Interferon-alpha in the treatment of myeloproliferative syndromes]. Ballarino P; Castello G; Lerza R Recenti Prog Med; 1994 Nov; 85(11):546-50. PubMed ID: 7855389 [TBL] [Abstract][Full Text] [Related]
11. Is interferon-alpha therapy safe and effective for patients with chronic hepatitis C and inflammatory bowel disease? A case-control study. Bargiggia S; Thorburn D; Anderloni A; Ardizzone S; Giorgi A; Bianchi Porro G; Parente F Aliment Pharmacol Ther; 2005 Aug; 22(3):209-15. PubMed ID: 16091058 [TBL] [Abstract][Full Text] [Related]
12. Use of oromucosally administered interferon-alpha in the prevention and treatment of animal diseases. Dec M; Puchalski A Pol J Vet Sci; 2008; 11(2):175-86. PubMed ID: 18683548 [TBL] [Abstract][Full Text] [Related]
13. Meta-analysis: interferon-alpha prevents the recurrence after curative treatment of hepatitis C virus-related hepatocellular carcinoma. Miyake Y; Takaki A; Iwasaki Y; Yamamoto K J Viral Hepat; 2010 Apr; 17(4):287-92. PubMed ID: 19732321 [TBL] [Abstract][Full Text] [Related]
14. Interferon-alpha as a treatment modality for colchicine- resistant familial Mediterranean fever. Tweezer-Zaks N; Rabinovich E; Lidar M; Livneh A J Rheumatol; 2008 Jul; 35(7):1362-5. PubMed ID: 18528960 [TBL] [Abstract][Full Text] [Related]
15. Aerosolized interferon-alpha treatment in patients with multi-drug-resistant pulmonary tuberculosis. Giosuè S; Casarini M; Ameglio F; Zangrilli P; Palla M; Altieri AM; Bisetti A Eur Cytokine Netw; 2000 Mar; 11(1):99-104. PubMed ID: 10705306 [TBL] [Abstract][Full Text] [Related]
16. Factors influencing long-term changes in mental health after interferon-alpha treatment of chronic hepatitis C. Schmidt F; Janssen G; Martin G; Lorenz R; Loeschke K; Soyka M; Folwaczny C; Schaefer M Aliment Pharmacol Ther; 2009 Nov; 30(10):1049-59. PubMed ID: 19691667 [TBL] [Abstract][Full Text] [Related]
17. Longterm efficacy of interferon-alpha for extrahepatic disease associated with hepatitis C virus infection. Naarendorp M; Kallemuchikkal U; Nuovo GJ; Gorevic PD J Rheumatol; 2001 Nov; 28(11):2466-73. PubMed ID: 11708420 [TBL] [Abstract][Full Text] [Related]
19. Randomized clinical trial of the effect of interferon alpha on survival in patients with disseminated midgut carcinoid tumours. Kölby L; Persson G; Franzén S; Ahrén B Br J Surg; 2003 Jun; 90(6):687-93. PubMed ID: 12808615 [TBL] [Abstract][Full Text] [Related]
20. The role of interferon-alpha in the management of myelomatosis. Avvisati G; Mandelli F Hematol Oncol Clin North Am; 1992 Apr; 6(2):395-405. PubMed ID: 1582981 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]